Cefamandole in the treatment of purulent respiratory infections. Studies of 3 and 4 g daily in 121 patients.
Cefamandole 3 g daily gave poor results in the treatment of severe purulent respiratory infections in 50 patients. A further 71 patients were treated with 4 g daily and the results were excellent with 86% clinical success. Apart from muscle pain with the injection, side-effects were minimal.